Detalles de la búsqueda
1.
Clonal architecture in patients with myelodysplastic syndromes and double or minor complex abnormalities: Detailed analysis of clonal composition, involved abnormalities, and prognostic significance.
Genes Chromosomes Cancer;
57(11): 547-556, 2018 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-30248204
2.
Azacitidine improves outcome in higher-risk MDS patients with chromosome 7 abnormalities: a retrospective comparison of GESMD and GFM registries.
Br J Haematol;
181(3): 350-359, 2018 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-29611196
3.
Twelve years of experience with miglustat in the treatment of type 1 Gaucher disease: The Spanish ZAGAL project.
Blood Cells Mol Dis;
68: 173-179, 2018 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-27836529
4.
Enumerating bone marrow blasts from nonerythroid cellularity improves outcome prediction in myelodysplastic syndromes and permits a better definition of the intermediate risk category of the Revised International Prognostic Scoring System (IPSS-R).
Am J Hematol;
92(7): 614-621, 2017 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-28370234
5.
Multidimensional assessment of patient condition and mutational analysis in peripheral blood, as tools to improve outcome prediction in myelodysplastic syndromes: A prospective study of the Spanish MDS group.
Am J Hematol;
92(9): E534-E541, 2017 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-28612357
6.
Excess mortality in the myelodysplastic syndromes.
Am J Hematol;
92(2): 149-154, 2017 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-27859564
7.
Prognostic impact of chromosomal translocations in myelodysplastic syndromes and chronic myelomonocytic leukemia patients. A study by the spanish group of myelodysplastic syndromes.
Genes Chromosomes Cancer;
55(4): 322-7, 2016 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-26690722
8.
Patients with type 1 Gaucher disease in Spain: A cross-sectional evaluation of health status.
Blood Cells Mol Dis;
56(1): 23-30, 2016 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-26603719
9.
Erythroleukemia shares biological features and outcome with myelodysplastic syndromes with excess blasts: a rationale for its inclusion into future classifications of myelodysplastic syndromes.
Mod Pathol;
29(12): 1541-1551, 2016 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-27562492
10.
Response to erythropoietic-stimulating agents in patients with chronic myelomonocytic leukemia.
Eur J Haematol;
97(1): 33-8, 2016 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-26341961
11.
Validation of the revised international prognostic scoring system (IPSS-R) in patients with lower-risk myelodysplastic syndromes: a report from the prospective European LeukaemiaNet MDS (EUMDS) registry.
Br J Haematol;
170(3): 372-83, 2015 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-25907546
12.
Development and validation of a prognostic scoring system for patients with chronic myelomonocytic leukemia.
Blood;
121(15): 3005-15, 2013 Apr 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-23372164
13.
Interstitial 13q14 deletions detected in the karyotype and translocations with concomitant deletion at 13q14 in chronic lymphocytic leukemia: different genetic mechanisms but equivalent poorer clinical outcome.
Genes Chromosomes Cancer;
53(9): 788-97, 2014 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-24915757
14.
Multivariate time-dependent comparison of the impact of lenalidomide in lower-risk myelodysplastic syndromes with chromosome 5q deletion.
Br J Haematol;
166(2): 189-201, 2014 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-24716538
15.
Single nucleotide polymorphism array karyotyping: a diagnostic and prognostic tool in myelodysplastic syndromes with unsuccessful conventional cytogenetic testing.
Genes Chromosomes Cancer;
52(12): 1167-77, 2013 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-24123380
16.
Reciprocal translocations in myelodysplastic syndromes and chronic myelomonocytic leukemias: review of 5,654 patients with an evaluable karyotype.
Genes Chromosomes Cancer;
52(8): 753-63, 2013 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-23686965
17.
Clinical characteristics, prognosis and treatment of myelofibrosis patients with severe thrombocytopenia.
Br J Haematol;
181(3): 397-400, 2018 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-28419426
18.
Biallelic losses of 13q do not confer a poorer outcome in chronic lymphocytic leukaemia: analysis of 627 patients with isolated 13q deletion.
Br J Haematol;
163(1): 47-54, 2013 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-23869550
19.
Reproducibility of the World Health Organization 2008 criteria for myelodysplastic syndromes.
Haematologica;
98(4): 568-75, 2013 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-23065505
20.
Better prognosis for patients with del(7q) than for patients with monosomy 7 in myelodysplastic syndrome.
Cancer;
118(1): 127-33, 2012 Jan 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-21717439